Readmissions following umbilical cord blood stem cell transplantation von Crombie, Jennifer, Spring, Laura Michelle, Li, Shuli, Soiffer, Robert, Antin, Joseph Harry, Alyea, Edwin, Glotzbecker, Brett

Volltext

Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab von Filho, Otto Metzger, Viale, Giuseppe, Stein, Shayna, Trippa, Lorenzo, Yardley, Denise A, Mayer, Ingrid A, Abramson, Vandana G, Arteaga, Carlos L, Spring, Laura M, Waks, Adrienne G, Wrabel, Eileen, DeMeo, Michelle K, Bardia, Aditya, Dell'Orto, Patrizia, Russo, Leila, King, Tari A, Polyak, Kornelia, Michor, Franziska, Winer, Eric P, Krop, Ian E

Volltext

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic von Spring, Laura M, Specht, Michelle C, Jimenez, Rachel B, Isakoff, Steven J, Wang, Gary X, Ly, Amy, Shin, Jennifer A, Bardia, Aditya, Moy, Beverly

Volltext

A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry von Smith, Barbara L., Nguyen, Anvy, Korotkin, Jenna E., Kelly, Bridget N., Specht, Michelle C., Spring, Laura M., Moy, Beverly, Isakoff, Steven J., Gadd, Michele A.

Volltext

Broad overview of a clinical and commercial experience with CoolSculpting von Stevens, W Grant, Pietrzak, Laura K, Spring, Michelle A

Volltext

Ageing in place with non-medical home support services need not translate into dependence von Kuryk, Kaitlyn, Funk, Laura M., Warner, Grace, Macdonald, Marilyn, Lobchuk, Michelle, Rempel, Julie, Spring, Lauren, Keefe, Janice

Volltext

Abstract PD5-11: Pilot study to assess prolonged nightly fasting in breast cancer survivors (LONGFAST) von O'Donnell, Elizabeth K., Shapiro, Yael N., Comander, Amy, Isakoff, Steven J., Moy, Beverly, Spring, Laura, Wander, Seth, Kuter, Irene, Shin, Jennifer, Younger, Jerry, Specht, Michelle, Kourniotis, Chryssanthi, Sullivan, Carol, Winters, Loren, Horick, Nora, Peppercorn, Jeffrey

Volltext

Neoadjuvant HER2-targeted therapy ± immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial von McArthur, Heather L., Leal, Jorge, Shiao, Stephen Lawrence, Carter, Meredith, Basho, Reva K, Phillips, Michelle, Chan, David, Hool, Hugo, Park, Dorothy J., El-Masry, Mary, McAndrew, Philomena, Sikaria, Swati, Spring, Laura, Bardia, Aditya, Tighiouart, Mourad, Dadmanesh, Farnaz, Giuliano, Armando E., Sanchez, Katherine, Page, David B.

Volltext

Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast) von O’Donnell, Elizabeth, Shapiro, Yael, Comander, Amy, Isakoff, Steven, Moy, Beverly, Spring, Laura, Wander, Seth, Kuter, Irene, Shin, Jennifer, Specht, Michelle, Kournioti, Chryssanthi, Hu, Bonnie, Sullivan, Carol, Winters, Loren, Horick, Nora, Peppercorn, Jeffrey

Volltext

Neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open-label randomized phase II trial von McArthur, Heather L., Leal, Jorge Henrique S., Page, David B., Abaya, Christina DiLauro, Basho, Reva K, Phillips, Michelle, Chan, David, Hool, Hugo, Park, Dorothy J., El-Masry, Mary, McAndrew, Philomena, Sikaria, Swati, Spring, Laura, Bardia, Aditya, Tighiouart, Mourad, Dadmanesh, Farnaz, Giuliano, Armando E., Shiao, Stephen Lawrence

Volltext

Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses von Koh, Siang-Boon, Dontchos, Brian N., Bossuyt, Veerle, Edmonds, Christine, Cristea, Simona, Melkonjan, Nsan, Mortensen, Lindsey, Ma, Annie, Beyerlin, Kassidy, Denault, Elyssa, Niehoff, Elizabeth, Hirz, Taghreed, Sykes, David B., Michor, Franziska, Specht, Michelle, Lehman, Constance, Ellisen, Leif W., Spring, Laura M.

Volltext

Phase Ib trial to evaluate safety and anti-tumor activity of the AKT inhibitor, ipatasertib, in combination with endocrine therapy and a CDK4/6 inhibitor for patients with hormone... von Wander, Seth Andrew, Juric, Dejan, Supko, Jeffrey G., Micalizzi, Douglas Scott, Spring, Laura, Vidula, Neelima, Beeler, Maureen, Habin, Karleen R., Viscosi, Elene, Fitzgerald, Donna Michelle, Scarpetti, Lauren, Tripp, Elizabeth, Hepp, Rachel, Moy, Beverly, Isakoff, Steven J., Ellisen, Leif W., Bardia, Aditya

Volltext

Abstract P2-21-01: Feasibility of a multidisciplinary diagnostic breast research biopsy project von Beyerlin, Kassidy, Edmonds, Christine, Koh, Siang Boon, Bossuyt, Veerle, Ma, Annie, Jimenez, Rachel, Specht, Michelle, Smith, Barbara L, Dontchos, Brian, Sgroi, Dennis, Isakoff, Steven J, Lehman, Constance, Ellisen, Leif W, Spring, Laura M

Volltext

The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population von Beyerlin, Kassidy, Jimenez, Rachel, Zangardi, Mark, Fell, Geoffrey G, Edmonds, Christine, Johnson, Andrew, Bossuyt, Veerle, Specht, Michelle, Mulvey, Therese M, Moy, Beverly, Ellisen, Leif W, Isakoff, Steven J, Bardia, Aditya, Spring, Laura M

Volltext

A Community-Level Initiative to Prevent Obesity: Results From Kaiser Permanente’s Healthy Eating Active Living Zones Initiative in California von Cheadle, Allen, Atiedu, Akpene, Rauzon, Suzanne, Schwartz, Pamela M., Keene, Laura, Davoudi, Mehrnaz, Spring, Rebecca, Molina, Michelle, Lee, Lynda, Boyle, Kathryn, Williamson, Dana, Steimberg, Clara, Tinajero, Roberta, Ravel, Jodi, Nudelman, Jean, Azuma, Andrea Misako, Kuo, Elena S., Solomon, Loel

Volltext

Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes von Yakneen, Sergei, Waszak, Sebastian M., Gertz, Michael, Korbel, Jan O.

Volltext

Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer von Spring, Laura, Niemierko, Andrzej, Haddad, Stephanie, Yuen, Megan, Comander, Amy, Reynolds, Kerry, Shin, Jennifer, Bahn, Atul, Brachtel, Elena, Specht, Michelle, Smith, Barbara L., Taghian, Alphonse, Jimenez, Rachel, Peppercorn, Jeffrey, Isakoff, Steven J., Moy, Beverly, Bardia, Aditya

Volltext

HER2 heterogeneity as a predictor of response to neoadjuvant T-DM1 plus pertuzumab: Results from a prospective clinical trial von Metzger Filho, Otto, Viale, Giuseppe, Trippa, Lorenzo, Li, Tianyu, Yardley, Denise A., Mayer, Ingrid A., Abramson, Vandana Gupta, Arteaga, Carlos L., Spring, Laura, Waks, Adrienne Gropper, Janiszewska, Michalina, Wrabel, Eileen, Demeo, Michelle, Bardia, Aditya, King, Tari A., Polyak, Kornelia, Winer, Eric P., Krop, Ian E.

Volltext

Tolerability and effectiveness of pertuzumab-containing neoadjuvant (NA) regimens vs. AC-TH for HER2-positive (+) localized breast cancer (BC) von Spring, Laura, Niemierko, Andrzej, Comander, Amy H., Reynolds, Kerry Lynn, Sajer, Susan A., Shin, Jennifer, Brachtel, Elena F, Specht, Michelle Connolly, Smith, Barbara L., Taghian, Alphonse G., Peppercorn, Jeffrey M., Isakoff, Steven J., Moy, Beverly, Bardia, Aditya

Volltext

Abstract OT3-25-01: Neoadjuvant HER2-targeted Therapy +/- Immunotherapy with Pembrolizumab (neoHIP): An Open Label Randomized Phase II Trial von McArthur, Heather, Leal, Jorge Henrique Santos, Abaya, Christina DiLauro, Reddy, Sangeetha, Carter, Meredith, Basho, Reva, Phillips, Michelle, Chan, David, Hool, Hugo, Park, Dorothy, El-Masry, Mary, McAndrew, Philomena, Sikaria, Swati, Spring, Laura M., Bardia, Aditya, Tighiouart, Mourad, Dadmanesh, Farnaz, Giuliano, Armando, Shiao, Stephen, Page, David B.

Volltext